Journal article
Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system
- Abstract:
-
Background/objectives: The Government of Kerala initiated a pilot screening programme for diabetic retinopathy in 16 Family Health Centres in Thiruvananthapuram district in 2019 in collaboration with the ORNATE India project. The evaluation of this pilot included a study of its costs and cost-effectiveness to inform decisions about extending the programme throughout Kerala.
Subjects/methods: The participants comprise all 5307 people who were screened for diabetic retinopathy under the pilot programme for whom data could be collected.
Results: The costs of the pilot programme are estimated at INR 11.3 million (including INR 1.9 million costs to individuals) and the benefits at 514 QALYs, slightly over one QALY per person treated. The cost per QALY was INR 22,000, which is well below India’s Gross National Income per person.
Conclusions: Kerala’s 2019 pilot screening programme for diabetic retinopathy was highly cost-effective.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 386.1KB, Terms of use)
-
- Publisher copy:
- 10.1038/s41433-024-03304-w
Authors
- Funder identifier:
- https://ror.org/0187kwz08
- Publisher:
- Springer
- Journal:
- Eye More from this journal
- Volume:
- 38
- Issue:
- 17
- Pages:
- 3352–3356
- Place of publication:
- England
- Publication date:
- 2024-09-03
- Acceptance date:
- 2024-08-12
- DOI:
- EISSN:
-
1476-5454
- ISSN:
-
0950-222X
- Pmid:
-
39227383
- Language:
-
English
- Keywords:
- Pubs id:
-
2025413
- Local pid:
-
pubs:2025413
- Deposit date:
-
2024-09-13
Terms of use
- Copyright holder:
- Wittenberg et al.
- Copyright date:
- 2024
- Rights statement:
- © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record